The Effect of Sarpogrelate and High Dose Statin on the Reduction of Coronary Spasm

A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 200 participants.

Also called NCT01674686

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; single masking; primary purpose treatment
Phase
Phase 4
Enrolled
  • 200 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT01674686
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
South Korea (from the registry)
Registry status
  • Unknown status (from the registry)

Technical summary

Registry record NCT01674686. Randomized; single masking; primary purpose treatment. Start 2012-08-01 (actual); primary completion 2018-12-31 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
The Effect of Sarpogrelate and High Dose Statin on the Reduction of Coronary Spasm
Condition
Variant Angina
Intervention (Drug)
Sarpogrelate
Intervention (Drug)
Atorvastatin
Lead sponsor
Samsung Medical Center (class: other)

Record details

Record id
cardio:ct-nct01674686
Content hash
9dd7202f6fdb0be1d11d996a2ca3ac71d8bdf4e071fe59691ae0682b3b973ad2